An interventional study of education and standart medical treatment in Hypertension, sponsored by Inonu University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by Inonu University · Not applicable, Interventional, and Supportive care
Educational interventions play an extensive role in the literature on hypertension disease management. It has been reported that patient education practices increase individuals' level of knowledge, improve sleep and quality of life, ensure the control of hypertension, are effective in developing self-management skills, reduce body weight and body mass index, are effective in controlling harmful lifestyle habits, increase treatment adherence and healthy lifestyle behaviors, improve health literacy and self-efficacy levels, positively affect rational medication use, and strengthen adaptation to the disease. Accordingly, educational interventions for patients with hypertension play a fundamental role in improving treatment success and long-term health outcomes by supporting individuals' active participation in disease management. However, most studies conducted in the context of hypertension have focused on medication adherence, blood pressure control, or the physiological effects of lifestyle changes. In contrast, no study examining the effects of educational interventions for disease management on the health perception and burnout levels of individuals with hypertension has been found in the literature. The aim of this study is to determine the effects of disease management education provided to individuals diagnosed with hypertension on their health perception and burnout levels. The study aims to provide practical implications for both individual patient outcomes (psychosocial variables) and healthcare practices (the planning and implementation of patient education programs).
6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.
This study's planned enrollment of 76 is below the median of 90 across 5,095 interventional studies indexed under Hypertension.
Browse Hypertension studies →Inonu University is the lead sponsor of 384 studies on the registry; 90 are open to participants now.
Counted across the registry records on this site, refreshed daily.
**Inclusion Criteria**
**Exclusion Criteria**
participants in this group will take education
Other: education
Participants in this group will receive standard medical treatment only.
Other: standart medical treatment
Participants in this group will take education three times.
Participants in the control group will receive standard medical treatment only.
health perception will be measured using health perception scale.
The Health Perception Scale (HPS) was developed by Diamond et al. in 2007. The HPS is a five-point Likert-type scale consisting of 15 items and four subdimensions: "control center," "self-awareness," "certainty," and "importance of health." Positive statements include items 1, 5, 9, 10, 11, and 14, whereas items 2, 3, 4, 6, 7, 8, 12, 13, and 15 are negatively worded. Positive items are scored as follows: "strongly agree" = 5, "agree" = 4, "undecided" = 3, "disagree" = 2, and "strongly disagree" = 1. Negatively worded items are reverse-scored. The total score ranges from 15 to 75. Higher scores on the Health Perception Scale indicate that individuals perceive themselves as healthier. The Cronbach's alpha coefficients for the subdimensions of the scale are 0.90 for Control Center, 0.91 for Self-Awareness, 0.91 for Certainty, and 0.82 for Importance of Health.
Time frame: 3 months
burnout will be measured using burnout scale
The Short Version of the Burnout Measure, developed by Pines (28), is a self-report instrument designed to assess individuals' levels of burnout. The scale consists of 10 items and has a single-factor structure. The total score ranges from 10 to 70, with higher scores indicating higher levels of burnout.
Time frame: 3 months
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.